Global Stomach Cancer Drugs Market by Type (Chemo Drugs, Targeted Therapy Drugs, Biological Therapies, Others), By Application (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) and Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast From 2022 To 2030

                                          

                                                                                       
Market Overview:

The global stomach cancer drugs market is expected to grow at a CAGR of 7.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing incidence of stomach cancer, rising awareness about available treatment options, and technological advancements in the field of oncology. The global stomach cancer drugs market is segmented on the basis of type into chemo drugs, targeted therapy drugs, biological therapies, and others. The chemo drug segment is expected to dominate the market during the forecast period owing to its high adoption rate for treating various types of cancers including stomach cancer. On the basis of application, the hospital pharmacies segment is expected to account for a major share ofthe global stomach cancer drugs market duringthe forecast period owingtoits higher adoption rates for treating patients with advanced-stage tumors as comparedto other segments such as retail pharmacies and online pharmacies.



Get Free Sample Report

Product Definition:

Stomach cancer drugs are used to treat stomach cancer. They work by killing or stopping the growth of cancer cells in the stomach.

Chemo Drugs:

Chemo drugs are the medications used by cancer patients to fight off their illness. Chemotherapy is a group of medical treatments used to eliminate or reduce the spread of cancer. The most common types of chemotherapies include alkylating agents, cytotoxic agents, plant derivatives, and antimetabolites. These therapies work by damaging or destroying the cells that contain genetic mutations responsible for tumor growth.

Targeted Therapy Drugs:

Stomach cancer is one of the most common types of cancer in the world. According to estimates by WHO, it accounted for approximately 1.0 million deaths globally in 2012 and is expected to remain a key cause of global mortality until 2030. Stomach cancer has a poor prognosis with a survival rate below 5 years owing to late diagnosis and lack of targeted therapy drugs available for treatment till date.

Global stomach Cancer incidence (000s), survival rates (%).

Application Insights:

Based on application, the global market is segmented into hospital pharmacies, retail pharmacies and online pharmacies. Hospital pharmacy held the largest share of over 70% in 2017 owing to factors such as high usage of anti-cancer drugs for treating cancerous tumors and increasing prevalence of cancer across the globe.

The use of targeted therapy drugs for stomach cancer treatment is also a major factor contributing towards high share held by hospital pharmacies. For instance, palbociclib (ZD1839) is a targeted therapy drug that has been approved by U.S FDA for breast and other cancers but it can be used against non-small cell lung, endometrial and gastric carcinoma as well due to its resistance against mutational analysis property which makes it an ideal drug choice in this category.

Regional Analysis:

North America dominated the global market in 2017. This can be attributed to high healthcare expenditure, availability of effective treatment methods, and well-established healthcare infrastructure. Moreover, increasing prevalence of stomach cancer is also one of the major factors contributing to its largest share in this region. According to a recent study published by American Cancer Society (ACS), it was estimated that about 1,869 new cases were diagnosed in U.S., as well as 685 deaths were recorded for 2018 from the disease category itself (stomach cancer).

Asia Pacific is expected to witness lucrative growth during the forecast period owing to rising disposable income and improving healthcare infrastructure especially in developing countries such as China and India which are anticipated to contribute significantly towards market development over the next eight years. Furthermore, economic development coupled with growing awareness regarding early diagnosis will further boost regional growth during this period.

Growth Factors:

Increasing incidence of stomach cancer
Growing demand for better and more effective treatments for stomach cancer
Rising awareness about stomach cancer and its symptoms
Availability of government funding for research on stomach cancer drugs
Technological advancements in the development of new and more effective drugs for the treatment of stomach cancer


Get Free Sample Report
Scope Of The Report
Report Attributes
Report Details
Report Title
Stomach Cancer Drugs Market Research Report
By Type
Chemo Drugs, Targeted Therapy Drugs, Biological Therapies, Others
By Application
Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
By Companies
Pfizer, Eli Lilly, Sanofi, Kuhnil Pharm, Merck & Co, AstraZeneca, Novartis, Taiho Pharmaceutical, Mylan, Celgene Corporation, Boston Biomedical, Jiangsu Hengrui Medicine
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
218
Number of Tables & Figures
153
Customization Available
Yes, the report can be customized as per your need.

Global Stomach Cancer Drugs Market Report Segments:
The global Stomach Cancer Drugs market is segmented on the basis of:
Types
Chemo Drugs, Targeted Therapy Drugs, Biological Therapies, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
Pfizer
Eli Lilly
Sanofi
Kuhnil Pharm
Merck & Co
AstraZeneca
Novartis
Taiho Pharmaceutical
Mylan
Celgene Corporation
Boston Biomedical
Jiangsu Hengrui Medicine



Get Free Sample Report

Highlights of The Stomach Cancer Drugs Market Report:
The market structure and projections for the coming years.
Drivers, restraints, opportunities, and current trends of market.
Historical data and forecast.
Estimations for the forecast period 2030.
Developments and trends in the market.
By Type:
Chemo Drugs
Targeted Therapy Drugs
Biological Therapies
Others
By Application:
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Market scenario by region, sub-region, and country.
Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
Government Policies, Macro & Micro economic factors are also included in the report.

We have studied the Stomach Cancer Drugs Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
North America
Europe
Asia Pacific
Middle East & Africa
Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
Correctly Positioning New Products
Market Entry Strategies
Business Expansion Strategies
Consumer Insights
Understanding Competition Scenario
Product & Brand Management
Channel & Customer Management
Identifying Appropriate Advertising Appeals



8 Reasons to Buy This Report
Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
Implemented Robust Methodology to Prepare the Report
Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
Provides Information About the Top-winning Strategies Implemented by Industry Players.
In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
Customization of the Report Available

Frequently Asked Questions?